April 26, 2026 12:00 ET | Source: Oruka Therapeutics, Inc. MENLO PARK, Calif., April 26, 2026 (GLOBE NEWSWIRE) -- Oruka…
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical…
San Francisco, CA, Dec. 23, 2025 (GLOBE NEWSWIRE) -- PULSESUN Trading Center has completed a series of infrastructure and system-level…
93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell…
Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase…
October 24, 2025 11:39 ET | Source: PMV Pharmaceuticals, Inc. Data presented today as an oral presentation at 2025 AACR-NCI-EORTC…
Intention follows comprehensive strategic review process and would represent the optimal capital allocation pathway to support a stronger and sustainable…
- India faces an annual loss of approximately $1.65 billion, with 25% of the domestic market illicit and an estimated…
Aviva platform continues development of innovative technology to support advisers.The latest innovation, the Aviva Analytics tool, is now live with selected…
DUBAI, UAE, June 4, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has been writing a new…